161 related articles for article (PubMed ID: 38397925)
21. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD.
Gawrieh S; Vilar-Gomez E; Wilson LA; Pike F; Kleiner DE; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Kowdley KV; Hameed B; Tonascia J; Loomba R; Sanyal AJ; Chalasani N;
J Hepatol; 2024 May; ():. PubMed ID: 38762169
[TBL] [Abstract][Full Text] [Related]
22. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
Demir M; Deyneli O; Yılmaz Y
Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
[TBL] [Abstract][Full Text] [Related]
23. A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
Stern C; Ngo A; Villela-Nogueira C; Thabut D; Ratziu V
Dig Dis Sci; 2024 Apr; ():. PubMed ID: 38678527
[TBL] [Abstract][Full Text] [Related]
24. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
[TBL] [Abstract][Full Text] [Related]
25. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
Kumada T; Toyoda H; Yasuda S; Ogawa S; Gotoh T; Ito T; Tada T; Tanaka J
AJR Am J Roentgenol; 2022 Oct; 219(4):604-612. PubMed ID: 35506556
[No Abstract] [Full Text] [Related]
26. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
[TBL] [Abstract][Full Text] [Related]
27. Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.
Hayashi H; Kamada Y; Fujii H; Takahashi H; Oeda S; Iwaki M; Kawaguchi T; Tomita E; Yoneda M; Tokushige A; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
Ultrasound Med Biol; 2023 Jul; 49(7):1658-1664. PubMed ID: 37120329
[TBL] [Abstract][Full Text] [Related]
28. Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A "Real-Life" Cohort Study.
Popa A; Bende F; Șirli R; Popescu A; Bâldea V; Lupușoru R; Cotrău R; Fofiu R; Foncea C; Sporea I
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33926073
[TBL] [Abstract][Full Text] [Related]
29. Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
Kuroda H; Fujiwara Y; Abe T; Nagasawa T; Oguri T; Noguchi S; Kamiyama N; Takikawa Y
PLoS One; 2021; 16(4):e0249493. PubMed ID: 33826669
[TBL] [Abstract][Full Text] [Related]
30. Accuracy and concordance of two-dimensional shear-wave elastography using transient elastography as the reference in chronic viral hepatitis and HIV infection in Rio de Janeiro, Brazil.
Coelho M; Fernandes F; Cardoso SW; Piedade J; Torres da Silva MV; Santos R; Veloso VG; Grinsztejn B; Pereira GH; Perazzo H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):583-590. PubMed ID: 36966773
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and Determinants of Undiagnosed Liver Steatosis and Fibrosis in a Nationally Representative Sample of US Adults.
Bhattacharyya M; Nickols-Richardson SM; Miller AL; Bhattacharyya R; Frankhauser F; Miller LE
Cureus; 2023 Oct; 15(10):e46783. PubMed ID: 37954822
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
Fuhri Snethlage CM; Meijnikman AS; Mak AL; Rampanelli E; Voermans B; Callender CAK; de Groen P; Roep BO; van Raalte DH; Knop FK; Holleboom AG; Nieuwdorp M; Hanssen NMJ
Eur J Endocrinol; 2024 May; 190(5):391-400. PubMed ID: 38679966
[TBL] [Abstract][Full Text] [Related]
33. Assessment of clinically significant portal hypertension by two-dimensional shear wave elastography.
Grgurevic I; Madir A; Trkulja V; Bozin T; Aralica G; Podrug K; Mikolaševic I; Tsochatzis E; O'Beirne J; Pinzani M
Eur J Clin Invest; 2022 Jun; 52(6):e13750. PubMed ID: 35040495
[TBL] [Abstract][Full Text] [Related]
34. Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography.
Bauer DJ; Matic V; Mare R; Maiocchi L; Chromy D; Müllner-Bucsics T; Mandorfer M; Mustapic S; Sporea I; Ferraioli G; Grgurevic I; Reiberger T
Ultraschall Med; 2023 Apr; 44(2):169-178. PubMed ID: 35226932
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
Ding Y; Jiang L; Wang Q; Zhao W; Zhou X; Lu J; Tian T; Yu C; Xu X; Guo W; Zhang Q; Song C
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101951. PubMed ID: 35605893
[TBL] [Abstract][Full Text] [Related]
36. Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with psoriasis: A cross-sectional study.
Aksoy AN; Hanci B; Baskent MF; Umutlu EG; Kumas EN; Emanet SU; Yalcin MO; Duzyol Z; Teker AG; Yilmaz Y
Hepatol Forum; 2024; 5(1):29-32. PubMed ID: 38283270
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus.
Yu H; Liu H; Zhang J; Jia G; Yang L; Zhang Q; Li G; Liu F; Di F; Wang F
Ann Palliat Med; 2021 Sep; 10(9):9702-9714. PubMed ID: 34628896
[TBL] [Abstract][Full Text] [Related]
38. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
[TBL] [Abstract][Full Text] [Related]
39. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
[TBL] [Abstract][Full Text] [Related]
40. Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease.
P V Alves V; T Trout A; Dewit M; Mouzaki M; Arce-Clachar AC; S Bramlage K; R Dillman J; A Xanthakos S
Child Obes; 2023 Oct; 19(7):461-469. PubMed ID: 36269577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]